| Mar 5 2015 |
The Apotex Case: Current Good Manufacturing Practices (cGMP) violations |
Mahany Law |
| Mar 4 2015 |
Ascertainability Saps Plaintiffs’ Energy in Dietary Supplement Class Action |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 4 2015 |
Still Waiting for ADA and GINA Guidance on Wellness Incentives |
Jackson Lewis P.C. |
| Mar 3 2015 |
No Longer at Lager-Heads: Anheuser-Busch Settles Claim over Kirin Beer’s Origin |
Proskauer Rose LLP |
| Mar 3 2015 |
APHIS Withdraws 2008 Proposal to Amend Regulation of GE Organisms: Animal and Plant Health Inspection Service |
Beveridge & Diamond PC |
| Mar 3 2015 |
Third Circuit Affirms MillerCoors Victory in Wholesaler Contract Dispute |
McDermott Will & Emery |
| Mar 3 2015 |
Details Of The European Commission’s Legal Analysis Of ‘Reverse Patent Settlement Agreements’ Revealed |
Covington & Burling LLP |
| Mar 2 2015 |
Drones May Soon Take Off in Agriculture Industry |
Barnes & Thornburg LLP |
| Mar 2 2015 |
Federal Circuit Upholds Patent Term Adjustment Deduction For IDS Filed After Restriction Requirement |
Foley & Lardner LLP |
| Mar 2 2015 |
NASDA Supports National Uniform Labeling Policy for Genetically Modified Foods --National Association of State Departments of Agriculture |
Varnum LLP |
| Mar 1 2015 |
A Second Look At The Innovation Act Obviousness Type Double Patenting Statute |
Foley & Lardner LLP |
| Feb 27 2015 |
Grants Available for Specialty Crops – March 26 Deadline |
Varnum LLP |
| Feb 27 2015 |
FDA Proposal to Regulate Laboratory Developed Tests Raises Legal Liability Questions for Labs |
Covington & Burling LLP |
| Feb 27 2015 |
FTC to Accelerate Oncology Drug Growth, Requires Novartis to Divest Two Protein Inhibitors in Its Clinical Development Pipeline |
Mintz |
| Feb 25 2015 |
The Court’s Decision in the FLANAX US Trademark Dispute Gives Bayer a Headache |
Mintz |
| Feb 24 2015 |
Pharmaceutical Uses Acquisition to Make Itself More Competitive |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
| Feb 24 2015 |
Early Signs of Continued Focus on Food Information, Authenticity and Traceability? |
Squire Patton Boggs (US) LLP |
| Feb 24 2015 |
CMS Takes a Measured Approach to Medicare Advantage and Part D Plan Payment Rates and Policy Changes for 2016: Increased Part D Drug Costs Set the Stage for Higher Beneficiary Premiums |
Epstein Becker & Green, P.C. |
| Feb 23 2015 |
FDA Issues Final Guidance Documents on Medical Device Data Systems and Medical Mobile Apps |
Barnes & Thornburg LLP |
| Feb 20 2015 |
Deja Vu All Over Again: Federal GMO Labeling Legislation Re-Introduced |
Mintz |
| Feb 19 2015 |
Go For De Novo: FDA’s Revised Approach to Medical Device Accessories |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 19 2015 |
Life Sciences: Protecting the Crown Jewels |
Sills Cummis & Gross P.C. |
| Feb 18 2015 |
M&A, Investment or Partnering Checklist for Medtech Companies |
Greenberg Traurig, LLP |
| Feb 18 2015 |
FDA Issues Guidance for Mobile Medical Applications: What Will be Subject to FDA Oversight and Enforcement? |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 18 2015 |
Device Manufacturer Settles False Claims Act Allegations with DOJ for $1.25 Million |
Mintz |
| Feb 18 2015 |
Growing Issues In A Miniature World: Nanomaterial Registers In The EU |
Squire Patton Boggs (US) LLP |
| Feb 16 2015 |
Revised Seed Law Expected to Come into Effect Soon in China |
Michael Best & Friedrich LLP |
| Feb 13 2015 |
DEA Rules On Disposal of Controlled Substances - What's Up? |
Poyner Spruill LLP |
| Feb 12 2015 |
Prescribing and Telemedicine: The “Physical” Exam |
Epstein Becker & Green, P.C. |
| Feb 12 2015 |
Interface without Regulation – FDA Deregulates MDDS and Related Technologies |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 12 2015 |
Medicare Fraud Plea in Detroit Pill Mill Case |
Mahany Law |
| Feb 12 2015 |
Filthy Pharma Chronicles – GVK Bio Fake Drug Trials |
Mahany Law |
| Feb 12 2015 |
Pharmaceutical Manufacturer Agrees to Pay U.S. Government $7.9 Million for Alleged Kickback Scheme |
Tycko & Zavareei LLP |
| Feb 11 2015 |
FDA Will Not Enforce Regulatory Controls for Medical Device Data Systems and Two Other Health IT Devices |
McDermott Will & Emery |
| Feb 11 2015 |
European Study Finds Moderate Caffeine Use Safe |
Morgan, Lewis & Bockius LLP |
